By implanting the DOX-loaded nanofibers after tumor resection, the sustainedly released DOX was able to inhibit tumor recurrence, however, which inevitably induced drug resistance via promoting Bcl-2 overexpression. The gene discussed is BCL2; the disease is neoplasm.